These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 10082576)

  • 1. Atm is dispensable for p53 apoptosis and tumor suppression triggered by cell cycle dysfunction.
    Liao MJ; Yin C; Barlow C; Wynshaw-Boris A; van Dyke T
    Mol Cell Biol; 1999 Apr; 19(4):3095-102. PubMed ID: 10082576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional interaction of H2AX, NBS1, and p53 in ATM-dependent DNA damage responses and tumor suppression.
    Kang J; Ferguson D; Song H; Bassing C; Eckersdorff M; Alt FW; Xu Y
    Mol Cell Biol; 2005 Jan; 25(2):661-70. PubMed ID: 15632067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chk2 is a tumor suppressor that regulates apoptosis in both an ataxia telangiectasia mutated (ATM)-dependent and an ATM-independent manner.
    Hirao A; Cheung A; Duncan G; Girard PM; Elia AJ; Wakeham A; Okada H; Sarkissian T; Wong JA; Sakai T; De Stanchina E; Bristow RG; Suda T; Lowe SW; Jeggo PA; Elledge SJ; Mak TW
    Mol Cell Biol; 2002 Sep; 22(18):6521-32. PubMed ID: 12192050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ataxia-telangiectasia mutated is not required for p53 induction and apoptosis in irradiated epithelial tissues.
    Gurley KE; Kemp CJ
    Mol Cancer Res; 2007 Dec; 5(12):1312-8. PubMed ID: 18171989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of p53 renders ATM-deficient mice refractory to hepatocarcinogenesis.
    Teoh N; Pyakurel P; Dan YY; Swisshelm K; Hou J; Mitchell C; Fausto N; Gu Y; Farrell G
    Gastroenterology; 2010 Mar; 138(3):1155-65.e1-2. PubMed ID: 19919837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of p53 by oxidative stress involves platelet-derived growth factor-beta receptor-mediated ataxia telangiectasia mutated (ATM) kinase activation.
    Chen K; Albano A; Ho A; Keaney JF
    J Biol Chem; 2003 Oct; 278(41):39527-33. PubMed ID: 12890678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53 gain-of-function cancer mutants induce genetic instability by inactivating ATM.
    Song H; Hollstein M; Xu Y
    Nat Cell Biol; 2007 May; 9(5):573-80. PubMed ID: 17417627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncogenes and the DNA damage response: Myc and E2F1 engage the ATM signaling pathway to activate p53 and induce apoptosis.
    Hong S; Pusapati RV; Powers JT; Johnson DG
    Cell Cycle; 2006 Apr; 5(8):801-3. PubMed ID: 16582589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p19(ARF) is dispensable for oncogenic stress-induced p53-mediated apoptosis and tumor suppression in vivo.
    Tolbert D; Lu X; Yin C; Tantama M; Van Dyke T
    Mol Cell Biol; 2002 Jan; 22(1):370-7. PubMed ID: 11739748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atm selectively regulates distinct p53-dependent cell-cycle checkpoint and apoptotic pathways.
    Barlow C; Brown KD; Deng CX; Tagle DA; Wynshaw-Boris A
    Nat Genet; 1997 Dec; 17(4):453-6. PubMed ID: 9398849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defining the ATM-mediated barrier to tumorigenesis in somatic mammary cells following ErbB2 activation.
    Reddy JP; Peddibhotla S; Bu W; Zhao J; Haricharan S; Du YC; Podsypanina K; Rosen JM; Donehower LA; Li Y
    Proc Natl Acad Sci U S A; 2010 Feb; 107(8):3728-33. PubMed ID: 20133707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defective p53 response and apoptosis associated with an ataxia-telangiectasia-like phenotype.
    Gueven N; Becherel OJ; Birrell G; Chen P; DelSal G; Carney JP; Grattan-Smith P; Lavin MF
    Cancer Res; 2006 Mar; 66(6):2907-12. PubMed ID: 16540636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction versus progression of brain tumor development: differential functions for the pRB- and p53-targeting domains of simian virus 40 T antigen.
    Sáenz Robles MT; Symonds H; Chen J; Van Dyke T
    Mol Cell Biol; 1994 Apr; 14(4):2686-98. PubMed ID: 8139568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. E2F1 uses the ATM signaling pathway to induce p53 and Chk2 phosphorylation and apoptosis.
    Powers JT; Hong S; Mayhew CN; Rogers PM; Knudsen ES; Johnson DG
    Mol Cancer Res; 2004 Apr; 2(4):203-14. PubMed ID: 15140942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of ATM/p53-dependent suppression of myc-induced lymphomas by Wip1 phosphatase.
    Shreeram S; Hee WK; Demidov ON; Kek C; Yamaguchi H; Fornace AJ; Anderson CW; Appella E; Bulavin DV
    J Exp Med; 2006 Dec; 203(13):2793-9. PubMed ID: 17158963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kotomolide A arrests cell cycle progression and induces apoptosis through the induction of ATM/p53 and the initiation of mitochondrial system in human non-small cell lung cancer A549 cells.
    Chen CY; Hsu YL; Tsai YC; Kuo PL
    Food Chem Toxicol; 2008 Jul; 46(7):2476-84. PubMed ID: 18511169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apoptosis associated with deregulated E2F activity is dependent on E2F1 and Atm/Nbs1/Chk2.
    Rogoff HA; Pickering MT; Frame FM; Debatis ME; Sanchez Y; Jones S; Kowalik TF
    Mol Cell Biol; 2004 Apr; 24(7):2968-77. PubMed ID: 15024084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor suppression by p53 in the absence of Atm.
    Bailey SL; Gurley KE; Hoon-Kim K; Kelly-Spratt KS; Kemp CJ
    Mol Cancer Res; 2008 Jul; 6(7):1185-92. PubMed ID: 18583527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Limited role of murine ATM in oncogene-induced senescence and p53-dependent tumor suppression.
    Efeyan A; Murga M; Martinez-Pastor B; Ortega-Molina A; Soria R; Collado M; Fernandez-Capetillo O; Serrano M
    PLoS One; 2009; 4(5):e5475. PubMed ID: 19421407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Etoposide induces G2/M arrest and apoptosis in neural progenitor cells via DNA damage and an ATM/p53-related pathway.
    Nam C; Doi K; Nakayama H
    Histol Histopathol; 2010 Apr; 25(4):485-93. PubMed ID: 20183801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.